K. R. Ostler

DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.

M. L. Le Beau, A. Melnick, M. Figueroa, 2010, Cancer research.

Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.

A. Naranjo, S. Gu, Qiwei Yang, 2012, Cancer research.

Molecular and Cellular Pathobiology Truncated DNMT 3 B Isoform DNMT 3 B 7 Suppresses Growth , Induces Differentiation , and Alters DNA Methylation in Human Neuroblastoma

S. Gu, Qiwei Yang, S. Cohn, 2012 .

TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.

J. Issa, J. Jelinek, M. Estecio, 2015, Cancer research.

Title TET 2 mutations affect non-CpG island DNA methylation at enhancers and transcription factor binding sites in chronic myelomonocytic leukemia

J. Issa, J. Jelinek, M. Estecio, 2015 .

TET 2 mutations affect non-CpG island DNA methylation at enhancers and transcription factor binding sites in chronic myelomonocytic leukemia

J. Issa, J. Jelinek, M. Estecio, 2015 .

Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins

M. L. Beau, E. Davis, L. Godley, 2007, Oncogene.

Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage

K. Odunsi, Jihnhee Yu, L. Godley, 2011, Clinical Cancer Research.

Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia

J. Issa, J. Jelinek, Lanlan Shen, 2012, Epigenetics.

Characterization of NOL7 Gene Point Mutations, Promoter Methylation, and Protein Expression in Cervical Cancer

Alexander Langerman, Ravi Salgia, Timothy Best, 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines

Qiwei Yang, S. Cohn, L. Godley, 2010, BMC Cancer.

Implications of FLT3 mutations in the therapy of acute myeloid leukemia.

F. Locke, L. Godley, R. Mattison, 2007, Reviews on recent clinical trials.

The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells

J. Vardiman, J. Anastasi, L. Godley, 2008, Leukemia & lymphoma.